UBS on Boston Scientific (BSX): Risk/Reward Into 2026 Skewed to the Upside
Tweet Send to a Friend
UBS analyst Danielle Antalffy reiterated a Buy rating and $140.00 price target on Boston Scientific (NYSE: BSX).The analyst commented, "Ultimately ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
